Galaxy Biotech, LLC
Records under this name other than the patents Galaxy Biotech, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,605,070 | Antibody Molecules to TIM-3 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,884,913 | Antibody Molecules to TIM-3 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,472,419 | Antibody Molecules to TIM-3 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,981,990 | Antibody Molecules to TIM-3 and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,155,620 | Method of Detecting TIM-3 Using Antibody Molecules to TIM-3 Formerly held In force · High confidence | In force | High confidence | |
| US 8,101,725 | Monoclonal antibodies to basic fibroblast growth factor Lapsed on the fee record Ended Jan 24, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 24, 2024 | From the USPTO record |
| US 7,494,650 | Monoclonal antibodies to hepatocyte growth factor Lapsed on the fee record Ended Feb 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 24, 2021 | From the USPTO record |
| US 7,220,410 | Monoclonal antibodies to hepatocyte growth factor Lapsed on the fee record Ended May 22, 2019 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2019 | From the USPTO record |
| US 7,687,063 | Treating solid tumors with an antibody to hepatocyte growth factor Lapsed on the fee record Ended Mar 30, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2018 | From the USPTO record |
| US 8,628,778 | Humanized monoclonal antibodies to hepatocyte growth factor Lapsed on the fee record Ended Jan 14, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2018 | From the USPTO record |